Stock PRTA PROTHENA CORPORATION PLC
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Prothena Corporation plc

Equities

PRTA

IE00B91XRN20

Real-time Estimate Cboe BZX
Other stock markets
 11:39:21 2024-06-04 EDT 		5-day change 1st Jan Change
22.44 USD +1.20% Intraday chart for Prothena Corporation plc +13.53% -37.67%
05-28 Prothena to Receive $80 Million From Bristol-Myers Squibb For PRX019 Global License MT
05-28 Prothena Announces Bristol Myers Squibb Opt-In for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
PROTHENA CORPORATION PLC
Bio Therapeutic Drugs
+1.94%+13.53%-37.67%-67.30%+132.31% 1.19B
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. PRTA Stock
  4. Charts Prothena Corporation plc
  5. Comparison Chart